ESNM Webinars

Our webinars give you an opportunity to stay at the forefront of our rapidly evolving field Neurogastroenterology and Motility. Join us to update your knowledge and engage with leaders, experts and the ESNM network.

Webinar Series 2024

1st International School of Gut Microbiota in Digestive Disease

The human gut microbiota is composed by trillions of bacteria, viruses and fungi living in symbiosis with the host and playing a central role in human life. The huge knowledge that we have gained in only two decades since the advent of culture independent techniques, has brought gut microbiota in central stage in the field of medical sciences. Gut dysbiosis participates in the pathogenesis of several intestinal and extra-intestinal diseases including inflammatory bowel disease, diverticular disease, celiac disease, and disorders of gut-brain interaction, neuropsychiatric and metabolic disorders. Nonetheless, we are still in the ascending phase of the knowledge curve in this field and many gaps remain in our understanding.

It is time for the clinician to take advantage of the potential of microbiota-related diagnostic tools and gut microbiota-based dietary, natural and pharmacological approaches including prebiotics, probiotics, postbiotics, antibiotics, and fecal microbiota transplantation. The translation of gut microbiota modulation therapies in clinical practice requires an accurate evaluation of their efficacy, risks and long-term effects.

The participants in the 1st International School of Gut Microbiota in Digestive Disease will have the opportunity to interact with key opinion leaders that will serve as faculty in this unique event.

Please note: the official language of the course is English. Simultaneous translation from English into Italian and Spanish will be provided. The webinar course is supported with a grant from Bromatech. The programme of these webinars have been independently developed and approved by the European Society of Neurogastroenterology and Motility (ESNM) and its faculty members.

BY INVITATION ONLY – FOR HEALTHCARE PROFESSIONALS • info@isgm2024.com

Scientific Committee & Faculty

1st International School of Gut Microbiota in Digestive Disease

  • Prof. Giovanni Barbara (Italy)
  • Dr. Giovanni Marasco (Italy)
  • Dr. Marcello Romeo (Italy)

 

Dr. Sari Arponen (Spain) - Speaker  MD, Spec. in Internal Medicine, Master’s degrees in Clinical Psychoneuroimmunology, Genomic and Precision Nutrition, Infectious Diseases, HIV and Expertise in Microbiomics and Lifestyle Medicine

Prof. Qasim Aziz (UK) – Moderator  Professor of Neurogastroenterology at Queen Mary University of London, President of European Society of Neurogastroenterology and Motility (ESNM), Member of the Educational Committee of United European Gastroenterology Federation (UEGF)

Prof. Giovanni Barbara (Italy) – Moderator/Speaker  Full Professor of Internal Medicine, MD, Spec. in Gastroenterology, Dpt. of Medical and Surgical Sciences, Sant’Orsola Malpighi Hospital University of Bologna, Past President of ESNM, Executive Board Chair of GMFH

Dr. Maria Raffaella Barbaro (Italy) – Speaker  Biologist and researcher, PhD in Cellular, Molecular and Industrial Biology – Molecular and Functional Biology, Dpt. of Medical and Surgical Sciences, Sant’Orsola Malpighi Hospital, University of Bologna

Prof. Premysl Bercik (Canada) – Speaker Full Professor, Division of Gastroenterology, Member of the Farncombe Family Digestive Health Research Institute, McMaster University

Prof. John Cryan (Ireland) – Speaker  Professor and Chair, Dpt. of Anatomy & Neuroscience, Principal Investigator in the APC Microbiome Institute, University College Cork 

Prof. Francisco Guarner (Spain) – Speaker  MD, Spec. in Internal Medicine, Gastroenterology and Hepatology, Consultant of Gastroenterology, Digestive System Research Unit, Head of the Experimental Laboratory and Member of the Scientific Committee of the Research Institution, University Hospital Vall d’Hebron, Barcelona, Member of the Board of Directors of the International Scientific Association for Probiotics and Prebiotics, Member of the Steering Committee of the International Human Microbiome Consortium

Prof. Dirk Haller (Germany) – Speaker  Full Professor and Chair of Nutrition and Immunology, School of Life Sciences, Director of Corporate Research Institute, Food & Health, Technical University of Munich, Collaborative Research Center Coordinator, Microbiome Signatures – Functional Relevance in the Digestive Tract, German Research Foundation (DFG)

Dr. Giovanni Marasco (Italy) - Moderator  MD, Spec. in Gastroenterology, PhD, Researcher of Internal Medicine, Dpt. of Medical and Surgical Sciences, Sant’Orsola Malpighi Hospital, University of Bologna

Dr. Marcello Romeo (Italy) – Speaker MD, PhD in Biomedicine and Neuroscience, Lecturer for Master’s Degree in Human Nutrition University of Pavia

Prof. Magnus Simren (Sweden) – Speaker Professor of Gastroenterology, University of Gothenburg, Consultant, Dpt. of Internal Medicine Sahlgrenska University Hospital Gothenburg

January 30th 2024 from 8.30 to 10.30 pm CET
  • Moderator: Qasim Aziz (UK)

8.30 – 9.10 pm CET  The role of gut microbiota in the pathophysiology of IBS –Giovanni Barbara (Italy)
9.10 – 9.50 pm CET  Diet and gut microbiome interactions in IBS – Magnus Simren (Sweden)
9.50 – 10.20 pm CET  Probiotic modulation in DGBI – Marcello Romeo (Italy)
10.20 – 10.30 pm CET  Concluding questions and remarks 

 

February 6th 2024 from 8.30 to 10.30 pm CET
  • Moderator: Giovanni Barbara (Italy)

8.30 – 9.10 pm CET Highlights of gut microbiota in 2023 – Francisco Guarner (Spain)
9.10 – 9.50 pm CET Gut microbiota in IBD: evidence and perspectives – Dirk Haller (Germany)
9.50 – 10.20 pm CET Diet and probiotic modulation in IBD – Sari Arponen (Spain)
10.20 – 10.30 pm CET Concluding questions and remarks

February 13th 2024 from 8.30 to 10.30 pm CET
  • Moderator: Giovanni Marasco (Italy)

8.30 – 9.10 pm CET Gut microbiota in diverticular disease – Maria Raffaella Barbaro (Italy)
9.10 – 9.50 pm CET Gut microbiota in celiac disease and gluten sensitivity – (TBD)
9.50 – 10.20 pm CET Probiotic modulation in diverticular disease and celiac disease – Sari Arponen (Spain)
10.20 – 10.30 pm CET Concluding questions and remarks

February 20th 2024 from 8.30 to 10.30 pm CET
  • Moderator: Giovanni Barbara (Italy)

8.30 – 9.10 pm CET Neurobiological basis of stress-related neuropsychiatric disorders – John Cryan (Ireland)
9.10 – 9.50 pm CET Microbiota-brain axis in DGBI – Premysl Bercik (Canada)
9.50 – 10.20 pm CET Diet and probiotic modulation – Marcello Romeo (Italy)
10.20 – 10.30 pm CET Concluding questions and remarks

Webinar Series 2023

"Speed Date with Experts"

The European Society of Neurogastroenterology and Motility and the Turkish Society of Gastroenterology organised a webinar series in 2022/2023 called "Speed Date with Experts".

In these monthly webinars, the latest achievements in our field were presented by world-renowned experts in just 60 minutes! Each webinar consisted of three presentations from basic science, clinical science and an interesting case.

Each presentation lasted 12 minutes, followed by a question and answer session led by the chairs Eduardo Savarino (University of Padua, Padua, Italy) and Serhat Bor (Ege University, Izmir, Turkey).

Webinar Series 2022

"Clostridioides difficile"

In a series of 7 webinar this programme will develop a full picture of the C. difficile infection (CDI) reaching from the importance of a healthy gut microbiota, to its detection and testing methods to current and future therapeutic approaches.

The course will be held by a distinguished Faculty with expertise in the fields of neurogastroenterology, functional gastrointestinal disorders and microbiota. Our aim is to promote the dissemination of information and stimulate interesting live discussions that would ultimately improve the healthcare of our patients.

Please note: the official language of the course is English. Simultaneous translation will not be provided. The webinar course is supported with a grant from Ferring Pharmaceutical. The programme of these webinars have been independently developed and approved by the European Society of Neurogastroenterology and Motility (ESNM) and its faculty members.

About this webinar

Clostridioides (previously known as Clostridium) difficile (C. difficile) is a key cause of healthcare-associated infections and poses a substantial public health threat that carries high morbidity and mortality rates, especially amongst affected elderly patients (>65 years). C. difficile infection (CDI) also places a considerable burden on healthcare systems worldwide, with up to one-third of patients who develop an initial episode of CDI subsequently going on to develop a recurrence.

C. difficile bacteria is widely found in the environment, especially in the soil, and in the digestive system of animals and humans. In healthy individuals, a healthy gut microbiota comprising a broad consortium of micro-organisms is able to prevent C. difficile from multiplying to harmful levels in the gut and thus provide resistance against CDI. However, disruption of the composition and/or diversity (i.e. dysbiosis) of the gut microbiota allows proliferation of C. difficile and the subsequent production of toxins that lead to clinical symptoms of CDI, which range from mild diarrhoea through to, in severe and complicated cases, toxic megacolon, and even death. In addition, the diagnosis and management of patients with CDI is often complicated due to the presence of other dysbiosis-associated co-morbidities (e.g. Crohn’s disease and ulcerative colitis), while emerging evidence suggests that there is an increased risk of post-infection irritable bowel syndrome following CDI.

Current clinical guidelines issued by infectious disease and/or gastroenterology societies in the United States and Europe recommend oral antibiotics (vancomycin, metronidazole or fidaxomicin) as first-line therapy for the initial episode of CDI, as well as for first recurrence of CDI, depending on the severity of the condition. While antibiotic treatment of CDI can resolve the infection, it can also maintain the microbiota in a disrupted state; thus, leaving a patient susceptible to recurrence of CDI and, ultimately, leading to a vicious cycle of recurrent disease.

The relationship between CDI and dysbiosis means that treatment approaches should also consider the impact on the gut microbiome. Indeed, this is reflected in clinical guidelines with the inclusion of non-antibiotic treatments, such as fecal microbiota transplantation and monoclonal antibody. In addition, different non-antibiotic modalities, such as antibodies, microbiota-based therapeutics and vaccines, are currently being actively investigated in the prevention or treatment of recurrent CDI.

While there is widespread scientific literature regarding CDI, there is still a need to better inform the wider medical community on the importance of recognising the microbiome-mediated nature of CDI and how different treatment modalities available can help to resolve the condition and/or restore the gut microbiota to avoid recurrence.

The gut microbiota – Tuesday, March 29, 2022

16:00 -17:00hrs (CET)

Chair: René van den Wijngaard, Amsterdam, The Netherlands

Importance of gut microbiota in Clostridioides difficile Infection, Joël Doré, Paris, France
A patient’s perspective on C. difficile, Gail P Attara, Gastrointestinal Society, Vancouver, Canada
Followed by Q&A with all chairs and speakers
 
 
Introduction to Clostridioides difficile infection – April 26, 2022

16:00 -17:00hrs (CEST)

Chair: Edoardo Savarino, Padova, Italy
Epidemiology and outcome of patients with Clostridioides difficile infection, Daniele Roberto Giacobbe, Genoa, Italy
IBD and IBS: “good” patients for bad Clostridioides difficile infection? Harry Sokol , Paris, France
Followed by Q&A with chairs and speakers

In order to join the webinar, please register for the event (free of charge). Once registered you will receive a confirmation email with the dial-in information for the webinar.
Pathogenesis of CDI – May 31, 2022

16:00 -17:00hrs (CEST)

Chair: Joël Doré, Paris, France
C. difficile as a model of dysbiosis: the role of microbiota and microbial metabolites, Ben Mullish, London, UK (rising star UEG 2021)
Overview on Clostridioides difficile infection pathogenesis, Ed Kujiper, Leiden, The Netherlands
Followed by Q&A with chairs and speakers


In order to join the webinar, please register for the event (free of charge). Once registered you will receive a confirmation email with the dial-in information for the webinar.
Clinical picture and testing of CDI – June 28, 2022

16:00 -17:00hrs (CEST)

Chair: Aonghus Lavelle, Cork, Ireland
Clinical features of Clostridioides difficile infection, (TBC)
Clostridioides difficile infection laboratory investigations: When and how, Frédéric Barbut, Paris, France
Followed by Q&A with chair and speakers

In order to join the webinar, please register for the event (free of charge). Once registered you will receive a confirmation email with the dial-in information for the webinar.
Treatment options for CDI – September 06, 2022

16:00 -17:00hrs (CEST)

Chair: Giovanni Barbara, Bologna, Italy
First-line management, Nicola Petrosillo, Rome, Italy
Faecal Microbiota Transplantation (FMT), Gianluca Ianiro, Rome Italy
Followed by Q&A with chairs and speakers

To join us for our webinar series you need to book for the event. Once registered you will receive a confirmation email with dial in details for the webinar. Please note: Registration link follows.

Prevention of recurrence and re-infections – October 12, 2022

16:00 -17:00hrs (CEST)

Chair: Daniel Pohl, Zurich, Switzerland
Management of recurrence of Clostridioides difficile infection, Steven Johnson, Buies Creek, North Carolina, USA
Management of severe Clostridioides difficile infection, Tariq Iqbal, Birmingham, United Kingdom
Followed by Q&A with all chairs and speakers

In order to join the webinar, please register for the event (free of charge). Once registered you will receive a confirmation email with the dial-in information for the webinar. Please note: Registration link follows.

Future perspectives – November 22, 2022

16:00 -17:00hrs (CET)

Chair: Qasim Aziz, London, United Kingdom
Clinical view on C. diff management in the future, Ben Mullish, United Kingdom
Future developments in microbiome research, Ken Blount, United States
Q&A Discussion

In order to join the webinar, please register for the event (free of charge). Once registered you will receive a confirmation email with the dial-in information for the webinar. Please note: Registration link follows.

ESNM-GMFH Webinar Faculty

Prof. Qasim Aziz (Speaker & Moderator & Programme Chair)
Professor of Neurogastroenterology at Queen Mary University of London - President of the European Society of Neurogastroenterology and Motility (ESNM) - Member of the United European Gastroenterology Federation Education Committee

Prof. Giovanni Barbara (Speaker & Moderator & Programme Chair)
Professor of Gastroenterology at University of Bologna - Gastroenterologist at Department of Medical and Surgical Sciences St. Orsola-Malpighi Hospital of Bologna - Past President of European Society of Neurogastroenterology and Motility (ESNM) – Chair of the ESNM Section Gut Microbiota and Health

Prof. Joël Doré (Speaker & Moderator & Programme Chair)
Research Director at the French Research Institute in Agricultural Sciences, INRA, Paris - Deputy Head of the MICALIS Institute “Food and Gut Microbiology for Human Health”

Prof. Daniel Pohl (Moderator & Programme Chair)
Professor of Gastroenterology at University Hospital Zurich Division of Gastroenterology and Hepatology – Treasurer of the European Society of Neurogastroenterology and Motility (ESNM)

Prof. Edoardo Savarino (Moderator)
Department of Surgery, Oncology and Gastroenterology - DiSCOG, University of Padova, ITALY

Prof. Harry Sokol (Speaker)
Full Professor of Gastroenterology at Sorbonne University of Paris - Gastroenterologist at Gastroenterology Department, Saint-Antoine Hospital of Paris

Prof. René van den Wijngaard (Moderator)
Department of Gastroenterology and Hepatology, Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, Location AMC, THE NETHERLANDS

Previous videos

On our official YouTube channel you can find previous meetings of our webinar series on C. difficileinfection (CDI).

Copyright 2024